ACHC geopolitical news & exposure
ACHC geopolitical news and exposure. ACHC appears in 243 Geopolitics Alpha notes. The newest is 24 Sep 2026, 21:08 UTC. Stored price-reaction rows cover 0 of those notes.
- Grail multicancer detection test wins FDA advisers’ backing
24 Sep 2026, 21:08 UTC
- FDA nominee Overton parries vaccine questions at Senate hearing
24 Sep 2026, 20:46 UTC
- Merck reveals study success, and possible safety worries, for eye drug hopeful
24 Sep 2026, 15:34 UTC
- Lilly’s latest China drug deal; Immunovant’s setback in lupus
24 Sep 2026, 14:14 UTC
- Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4
24 Sep 2026, 10:22 UTC
- Oppenheimer Initiates Coverage of Pacira BioSciences with Outperform
24 Sep 2026, 07:36 UTC
- Oppenheimer Initiates Coverage of Amneal Pharmaceuticals at Outperform
24 Sep 2026, 00:33 UTC
- Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditions
23 Sep 2026, 19:50 UTC
- Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
23 Sep 2026, 19:31 UTC
- Enveda, an AI drugmaker, banks $311M in venture funding
23 Sep 2026, 17:55 UTC
- Roche, Ionis RNA drug scores in kidney disease study
23 Sep 2026, 16:21 UTC
- 9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe
23 Sep 2026, 15:13 UTC
- This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval
23 Sep 2026, 12:58 UTC
- FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.
23 Sep 2026, 12:39 UTC
- Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform
23 Sep 2026, 11:09 UTC
- Amgen reports a Phase 3 win with Sjögren’s drug candidate
22 Sep 2026, 18:31 UTC
- FDA Accepts Insmed's Filing Seeking Label Expansion for Arikayce
22 Sep 2026, 16:23 UTC
- Viking shares surge on updated obesity drug data
22 Sep 2026, 16:10 UTC
- This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
22 Sep 2026, 15:46 UTC
- Celldex sinks as safety concerns cloud immune drug results
22 Sep 2026, 15:42 UTC
- Notable ETF Outflow Detected - XBI, TWST, HALO, NTRA
22 Sep 2026, 15:05 UTC
- An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slide
22 Sep 2026, 14:17 UTC
- A hidden tradeoff in Trump’s drug pricing deals
22 Sep 2026, 11:00 UTC
- Cordis wins FDA approval for sirolimus-eluting balloon
22 Sep 2026, 09:56 UTC
- Novo CEO signals M&A opportunities to strengthen drug pipeline
22 Sep 2026, 09:00 UTC
- US strikes on alleged drug boats may be ‘crimes against humanity’, UN says
22 Sep 2026, 03:52 UTC
- Higher rates may not be bad for biotech stocks: find out more
21 Sep 2026, 21:06 UTC
- Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.
21 Sep 2026, 19:43 UTC
- Novo talks up drug launches in effort to win back investors
21 Sep 2026, 16:30 UTC
- Patient Listening Session Summaries
21 Sep 2026, 13:57 UTC
- FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing
21 Sep 2026, 12:58 UTC
- Drugs@FDA Data Files
21 Sep 2026, 12:57 UTC
- FDA Actions to Accelerate and Modernize Early and Late-Stage Clinical Development
21 Sep 2026, 12:57 UTC
- FDA Roundup: June 18, 2024
21 Sep 2026, 12:18 UTC
- US strikes on alleged drug boats could be crimes against humanity, says UN
21 Sep 2026, 12:08 UTC
- Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
21 Sep 2026, 12:06 UTC
- How J&J paved the way for Compass’ coming psychedelic drug launch
21 Sep 2026, 11:30 UTC
- Brazil pharmaceutical distributors face mounting financial pressure
21 Sep 2026, 11:20 UTC
- FDA
21 Sep 2026, 10:26 UTC
- Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain.
21 Sep 2026, 10:03 UTC